These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17264351)

  • 1. Stereotactic radiotherapy for centrally located early-stage lung tumors.
    Senan S; Haasbeek NJ; Smit EF; Lagerwaard FJ
    J Clin Oncol; 2007 Feb; 25(4):464; author reply 465. PubMed ID: 17264351
    [No Abstract]   [Full Text] [Related]  

  • 2. Stereotactic radiotherapy for nonsmall cell lung cancer.
    Ball D
    Curr Opin Pulm Med; 2008 Jul; 14(4):297-302. PubMed ID: 18520262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response on behalf of the UK Stereotactic Body Radiotherapy Consortium to Brock et al. Clin Oncol (R Coll Radiol) 2008;20(9):666-676.
    Franks KN; Jain P; Dahele M; Peedell C; Hatton MQ; Faivre-Finn C
    Clin Oncol (R Coll Radiol); 2009 Nov; 21(9):731-2. PubMed ID: 19717290
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypofractionated stereotactic radiotherapy for medically inoperable stage I non-small cell lung cancer--report on clinical outcome and dose to critical organs.
    Ng AW; Tung SY; Wong VY
    Radiother Oncol; 2008 Apr; 87(1):24-8. PubMed ID: 18334273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic radiation therapy for inoperable, early-stage non-small-cell lung cancer.
    Dahele M; Brade A; Pearson S; Bezjak A
    CMAJ; 2009 Jun; 180(13):1326-8. PubMed ID: 19546457
    [No Abstract]   [Full Text] [Related]  

  • 6. Stereotactic body radiation therapy for early-stage non-small-cell lung cancer.
    Lo SS; Fakiris AJ; Papiez L; Abdulrahman R; McGarry RC; Henderson MA; Forquer JA; Hoopes D; Timmerman RD
    Expert Rev Anticancer Ther; 2008 Jan; 8(1):87-98. PubMed ID: 18095886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy.
    Onimaru R; Fujino M; Yamazaki K; Onodera Y; Taguchi H; Katoh N; Hommura F; Oizumi S; Nishimura M; Shirato H
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):374-81. PubMed ID: 18029106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor lysis syndrome in solid tumors.
    Gemici C
    J Clin Oncol; 2009 Jun; 27(16):2738-9; author reply 2739. PubMed ID: 19380431
    [No Abstract]   [Full Text] [Related]  

  • 9. Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer.
    Zimmermann FB; Geinitz H; Schill S; Grosu A; Schratzenstaller U; Molls M; Jeremic B
    Lung Cancer; 2005 Apr; 48(1):107-14. PubMed ID: 15777977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-individualized stereotactic body radiotherapy for T1-3N0 non-small cell lung cancer: long-term results and efficacy of adjuvant chemotherapy.
    Chen Y; Guo W; Lu Y; Zou B
    Radiother Oncol; 2008 Sep; 88(3):351-8. PubMed ID: 18722684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial.
    Ricardi U; Filippi AR; Guarneri A; Giglioli FR; Ciammella P; Franco P; Mantovani C; Borasio P; Scagliotti GV; Ragona R
    Lung Cancer; 2010 Apr; 68(1):72-7. PubMed ID: 19556022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypofractionated stereotactic radiotherapy in the treatment of NSCLC in inoperable stage].
    Greco C
    Suppl Tumori; 2004; 3(2):S25-6. PubMed ID: 15067960
    [No Abstract]   [Full Text] [Related]  

  • 13. [Stereotactic radiotherapy following chemo-radiotherapy for lymph node metastasis of stage III non-small-cell lung cancer].
    Futamura Y; Sawa T; Hasegawa T; Horiba A; Ishiguro T; Yoshida T; Iida T; Marui T; Murakami E; Azuma K; Murakawa S
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2191-3. PubMed ID: 22202326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study.
    Onishi H; Shirato H; Nagata Y; Hiraoka M; Fujino M; Gomi K; Niibe Y; Karasawa K; Hayakawa K; Takai Y; Kimura T; Takeda A; Ouchi A; Hareyama M; Kokubo M; Hara R; Itami J; Yamada K; Araki T
    J Thorac Oncol; 2007 Jul; 2(7 Suppl 3):S94-100. PubMed ID: 17603311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Balancing the possible effectiveness of postoperative radiotherapy for non-small-cell lung cancer against the possible detriment of radiation-induced toxicity.
    Bonner JA; Tincher SA; Fiveash JB
    J Clin Oncol; 2001 Oct; 19(19):3905-7. PubMed ID: 11579109
    [No Abstract]   [Full Text] [Related]  

  • 16. Stereotactic radiotherapy for peripheral lung tumors: a comparison of volumetric modulated arc therapy with 3 other delivery techniques.
    Ong CL; Verbakel WF; Cuijpers JP; Slotman BJ; Lagerwaard FJ; Senan S
    Radiother Oncol; 2010 Dec; 97(3):437-42. PubMed ID: 21074878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans.
    Liang X; Penagaricano J; Zheng D; Morrill S; Zhang X; Corry P; Griffin RJ; Han EY; Hardee M; Ratanatharathom V
    Radiat Oncol; 2016 Jan; 11():10. PubMed ID: 26800883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypofractionated radiotherapy for advanced non-small-cell lung cancer: is the LINAC half full?
    Bogart JA
    J Clin Oncol; 2004 Mar; 22(5):765-8. PubMed ID: 14990629
    [No Abstract]   [Full Text] [Related]  

  • 19. Review of hypofractionated small volume radiotherapy for early-stage non-small cell lung cancer.
    Brock J; Ashley S; Bedford J; Nioutsikou E; Partridge M; Brada M
    Clin Oncol (R Coll Radiol); 2008 Nov; 20(9):666-76. PubMed ID: 18676130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical dose and toxicity index of organs at risk in radiotherapy: analyzing the calculated effects of modified dose fractionation in non-small cell lung cancer.
    Pedicini P; Strigari L; Benassi M; Caivano R; Fiorentino A; Nappi A; Salvatore M; Storto G
    Med Dosim; 2014; 39(1):23-30. PubMed ID: 24239409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.